彭布罗利珠单抗
医学
肿瘤科
佐剂
阶段（地层学）
新辅助治疗
肺癌
内科学
化疗
癌症
免疫疗法
乳腺癌
古生物学
生物
作者
Junghoon Shin,Sehhoon Park,Kyung Hwan Kim,Eui‐Cheol Shin,Hyun Ae Jung,Jong Ho Cho,Jong‐Mu Sun,Se‐Hoon Lee,Yong‐Soo Choi,Jin Seok Ahn,Jhingook Kim,Keunchil Park,Young Mog Shim,Hong Kwan Kim,Jae Myoung Noh,Yong Chan Ahn,Hongryull Pyo,Myung‐Ju Ahn
出处
期刊：Cancer Research and Treatment
[Korean Cancer Association]
日期：2024-04-30
卷期号：56 (4): 1084-1095
摘要
Optimal treatment for stage IIIA/N2 non-small cell lung cancer (NSCLC) is controversial. We aimed to assess the efficacy and safety of adjuvant pembrolizumab for stage IIIA/N2 NSCLC completely resected after neoadjuvant concurrent chemoradiation therapy (CCRT).
科研通智能强力驱动
Strongly Powered by AbleSci AI
8R60d8
嗯哼
Smith.w
爱吃巧克力
tuanheqi
VDC
杳鸢
YifanWang
寻道图强
HEIKU
guyutian
Darcy
带头大哥
psypsy
morena
Frank
俗人
Marciu33
精明的迎松
jyy
皖公网安备34019202002308
